back to homepage

Main News Slider

Midatech Completes Acquisition of Zuplenz from Galena Biopharma

Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, announced the successful completion of its previously announced acquisition of Zuplenz

Read More

FDA Wakes Up to Social Media’s Ability to Monitor Drug Adverse Events

Alec Gaffney reports that a recent FDA Notice of Solicitation (#1127679) calls for a “contractor capable of providing it with social media monitoring services capable of analyzing consumer sentiment and

Read More

Arena Pharma Announces Phase 1 Results for APD811

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today results from a Phase 1 clinical trial of APD811, an orally bioavailable agonist of the prostacyclin receptor which is intended for the treatment

Read More